Unlike other infections, COVID-19 exhibits concurrent elevation of immunoglobulin (Ig) G and IgM in the second week after disease onset, with IgM reaching peak titers in the second week and IgG in the third week of the disease (Long et al., 2020a; Sun et al., 2020). This evidence concerns the gene CD40LG and COVID-19.